Literature DB >> 20299043

Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer.

C J Stimson1, Michael S Cookson, Daniel A Barocas, Peter E Clark, John E Humphrey, Sanjay G Patel, Joseph A Smith, Sam S Chang.   

Abstract

PURPOSE: Preoperative hydronephrosis may be associated with a worse outcome in patients who undergo radical cystectomy for invasive bladder cancer. We characterized the prognostic significance of hydronephrosis, and its relationship to cancer stage and outcome. We also evaluated concordance between the side of identifiable hydronephrosis and concomitant pelvic lymph node metastasis.
MATERIALS AND METHODS: We analyzed information from our prospectively collected database of patients who underwent radical cystectomy for bladder cancer from January 2001 to December 2007. We examined the relationship between hydronephrosis and clinical variables as well as survival outcome. Hydronephrosis was diagnosed intraoperatively or by radiographic imaging within 3 months of radical cystectomy.
RESULTS: Of 753 patients 244 (32%) were diagnosed with hydronephrosis. Logistic regression modeling revealed that hydronephrosis was an independent predictor of extravesical disease (OR 2.01, 95% CI 1.37 to 2.96, p <0.001) and node positive disease (OR 1.94, 95% CI 1.29 to 2.91, p = 0.001). Of patients with hydronephrosis 88 (36.1%) had concomitant node positive disease and 74 (30.3%) had node positive disease on the same side as hydronephrosis. Thus, hydronephrosis predicted the side of nodal involvement in 74 of 88 patients (84%) with identifiable hydronephrosis and node positive disease.
CONCLUSIONS: Hydronephrosis is an independent predictor of advanced bladder cancer stage, and it predicts extravesical disease and node positive disease. Thus, it could prove useful to select patients for neoadjuvant chemotherapy before surgery. The strong correlation between hydronephrosis side and nodal metastasis may have implications for surgical staging and approach. 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20299043     DOI: 10.1016/j.juro.2010.01.028

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

Review 1.  Prognostic factors for upper urinary tract urothelial carcinoma.

Authors:  Thomas F Chromecki; Karim Bensalah; Mesut Remzi; Grégory Verhoest; Eugene K Cha; Douglas S Scherr; Giacomo Novara; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2011-07-05       Impact factor: 14.432

2.  Influence of preoperative hydronephrosis and ureteral orifice involvement in the survival of patients undergoing radical cystectomy: A retrospective comparative study.

Authors:  Ertuğrul Şefik; Serdar Çelik; Bülent Günlüsoy; İsmail Basmacı; Serkan Yarımoğlu; İbrahim Halil Bozkurt; Tansu Değirmenci; Çetin Dinçel
Journal:  Turk J Urol       Date:  2019-04-03

3.  [Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?].

Authors:  M May; M Burger; S Brookman-May; W Otto; J Peter; O Rud; H-M Fritsche; C Bolenz; L Trojan; E Herrmann; M S Michel; C Wülfing; R Moritz; A Tiemann; S C Müller; J Ellinger; A Buchner; C G Stief; D Tilki; W F Wieland; C Gilfrich; T Höfner; M Hohenfellner; A Haferkamp; J Roigas; P Bretschneider-Ehrenberg; O Müller; M Zacharias; S Gunia; P J Bastian
Journal:  Urologe A       Date:  2011-06       Impact factor: 0.639

4.  Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy.

Authors:  Jacob T Ark; Kirk A Keegan; Daniel A Barocas; Todd M Morgan; Matthew J Resnick; Chaochen You; Michael S Cookson; David F Penson; Rodney Davis; Peter E Clark; Joseph A Smith; Sam S Chang
Journal:  BJU Int       Date:  2014-04-03       Impact factor: 5.588

5.  Preoperative chronic kidney disease before radical cystectomy as predictor of oncological outcomes: a pick of the iceberg?

Authors:  Fabio Zattoni; Alessandro Morlacco; Filiberto Zattoni
Journal:  World J Urol       Date:  2018-02-07       Impact factor: 4.226

6.  Can preoperative imaging characteristics predict pT3 bladder cancer following cystectomy?

Authors:  Jay G Fuletra; Andrew Watts; Matthew G Kaag; Erik Lehman; Jay D Raman; Suzanne B Merrill
Journal:  World J Urol       Date:  2020-07-28       Impact factor: 4.226

7.  Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study.

Authors:  Patrick Mazza; George W Moran; Gen Li; Dennis J Robins; Justin T Matulay; Harry W Herr; Guarionex J Decastro; James M McKiernan; Christopher B Anderson
Journal:  J Urol       Date:  2018-05-19       Impact factor: 7.450

8.  External validation of existing nomograms predicting lymph node metastases in cystectomized patients.

Authors:  Miroslav M Stojadinovic; Rade I Prelevic
Journal:  Int J Clin Oncol       Date:  2014-04-11       Impact factor: 3.402

9.  Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.

Authors:  Stephen H Culp; Rian J Dickstein; H Barton Grossman; Shanna M Pretzsch; Sima Porten; Siamak Daneshmand; Jie Cai; Susan Groshen; Arlene Siefker-Radtke; Randall E Millikan; Bogdan Czerniak; Neema Navai; Matthew F Wszolek; Ashish M Kamat; Colin P N Dinney
Journal:  J Urol       Date:  2013-07-30       Impact factor: 7.450

10.  Scoring system for prediction of lymph node metastasis in radical cystectomy cohort.

Authors:  Miroslav M Stojadinović; Rade Prelević; Arso Vukićević
Journal:  Int Urol Nephrol       Date:  2014-01-29       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.